Pharmacokinetics for regulatory risk analysis: The case of 1,1,1-trichloroethane (methyl chloroform)
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 10 (1) , 26-50
- https://doi.org/10.1016/0273-2300(89)90011-1
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Linking Indoor Air and Pharmacokinetic Models to Assess Tetrachloroethylene RiskRisk Analysis, 1988
- Pharmacokinetics for regulatory risk analysis: The case of trichloroethyleneRegulatory Toxicology and Pharmacology, 1988
- Physiologically based pharmacokinetics and the risk assessment process for methylene chlorideToxicology and Applied Pharmacology, 1987
- Metabolism of inhaled dihalomethanes in vivo: Differentiation of kinetic constants for two independent pathwaysToxicology and Applied Pharmacology, 1986
- Regulatory history and experimental support of uncertainty (safety) factorsRegulatory Toxicology and Pharmacology, 1983
- STRUCTURE AND QUANTIFICATION OF A PHYSIOLOGICAL MODEL OF THE DISTRIBUTION OF INJECTED AGENTS AND INHALED ANAESTHETICSBritish Journal of Anaesthesia, 1981
- A chronometric approach to the study of feeding behaviorNeuroscience & Biobehavioral Reviews, 1980
- Metabolism, excretion and toxicology of methylchloroform in acute and subacute exposed ratsArchives of Toxicology, 1974
- Effect of phenobarbital and 3-methylcholanthrene pretreatment on the hepatotoxicity of 1,1,1-trichloroethane and 1,1,2-trichloroethaneLife Sciences, 1973
- The Metabolism of 1,1,1-Trichloroethane by the RatArchives of environmental health, 1960